Source: Citybizlist

PCI Pharma Services: PCI Pharma Services To Acquire Ajinomoto Althea

PHILADELPHIA-(BUSINESS WIRE)-PCI Pharma Services - a leading global contract development and manufacturing organization (CDMO) focused on innovative biopharma therapies - is... Read MoreThe post PCI Pharma Services To Acquire Ajinomoto Althea appeared first on citybiz.

Read full article »

PCI Pharma Services's Competitors | PCI Pharma Services's News | PCI Pharma Services's Financials

Followers on Owler

125

Est. Annual Revenue

$100-500M

Est. Employees

1.0-5.0K

CEO

Salim Haffar

CEO Approval Rating

- -/100

PCI is a Pennsylvania-based pharma company that provides services such as drug development, clinical trials, and packaging for the pharmaceutical industry.